Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Clinical trial NCT04336410 · COMPLETED

Trial details

NCT number: NCT04336410
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronavirus Infection

Start date: 2020-04-03
Primary completion: 2022-02-10
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.